Core Viewpoint - Hong Kong Stock Exchange (HKEX) is open to reviewing the "Weighted Voting Rights (WVR)" listing rules, indicating a willingness to adapt to market feedback and improve the listing system [1] Group 1: Listing Rules and Governance - HKEX has revised its listing rules, which now require boards to have a non-single gender composition and to include at least one director of a different gender [1] - The next step for HKEX is to establish a talent pool for female directors to ensure a steady supply of qualified candidates [1] Group 2: Market Position and Applications - HKEX is viewed as a stable and reliable market for US-listed Chinese companies considering a listing in Hong Kong, particularly due to its attractive interconnectivity trading mechanisms with mainland China [1] - Currently, HKEX is processing over 300 listing applications, with the actual number expected to be higher when including confidential submissions [1]

Group 1 - JPMorgan Chase & Co. increased its stake in Hong Kong Exchanges and Clearing Limited (00388.HK) by acquiring 681,221 shares at an average price of HKD 433.4691 per share, totaling approximately HKD 295 million [1] - Following this acquisition, JPMorgan's total holdings in Hong Kong Exchanges rose to 89,210,163 shares, increasing its ownership percentage from 6.98% to 7.03% [1]

Group 1 - JPMorgan Chase increased its stake in Hong Kong Exchanges and Clearing Limited (00388) by approximately 681,221 shares at a price of about HKD 433.47 per share, totaling around HKD 295 million [1] - Following the increase, JPMorgan's total shareholding in the company is approximately 89,210,200 shares, representing a holding percentage of 7.03% [1]

Group 1 - Morgan Stanley increased its stake in Hong Kong Exchanges and Clearing Limited (00388) by 681,221 shares at a price of HKD 433.4691 per share, totaling approximately HKD 295 million [1] - Following the increase, Morgan Stanley's total shareholding in Hong Kong Exchanges and Clearing Limited reached approximately 89,210,200 shares, representing a holding percentage of 7.03% [1]

Core Viewpoint - Hong Kong Exchanges and Clearing (HKEX) is expected to report strong financial results for Q3 2025, driven by increased trading activity and a robust IPO market, despite a decline in investment income due to lower HIBOR rates and currency fluctuations [1][2][3] Group 1: Financial Performance - Total revenue for Q3 2025 is projected to be HKD 7.583 billion, representing a year-on-year increase of 41% and a quarter-on-quarter increase of 5% [1] - Net profit attributable to shareholders is expected to reach HKD 4.774 billion, reflecting a year-on-year growth of 52% and a quarter-on-quarter growth of 7% [1] - Daily average trading volume (ADT) for Hong Kong stocks is anticipated to be HKD 286.4 billion, marking a year-on-year increase of 141% and a quarter-on-quarter increase of 20% [1] Group 2: Trading Activity - Trading-related revenue is expected to rise to HKD 5.137 billion, a quarter-on-quarter increase of 31% [1] - Southbound trading volume reached HKD 76.2 billion, a quarter-on-quarter increase of 36%, accounting for 26.6% of total ADT [1] - Northbound trading activity saw a significant increase, with single-sided ADT reaching RMB 134.3 billion, up 77% quarter-on-quarter [1] Group 3: IPO Market - IPO-related revenue for Q3 2025 is estimated at HKD 440 million, a quarter-on-quarter increase of 7.5% [2] - A total of 25 IPOs were recorded in Q3 2025, with a fundraising amount of HKD 73.5 billion, down from HKD 88 billion in Q2 2025 [2] - The number of newly listed structured products increased to 10,700, up from 9,494 in the previous quarter [2] Group 4: Investment Income - Net investment income is projected to decline to HKD 917 million, a quarter-on-quarter decrease of 41% [2] - The decline is attributed to reduced margins from margin investments due to HIBOR fluctuations and a decrease in the company's own investment returns [2] Group 5: Profit Forecast and Valuation - Net profit forecasts for 2025, 2026, and 2027 have been adjusted to HKD 17.7 billion, HKD 18.3 billion, and HKD 18.7 billion, respectively, with increases of 5.2%, 11.2%, and 14.1% [3] - The target price based on DCF remains at HKD 542, with a cost of equity of 5% [3]

Core Viewpoint - The 10th China Pharmaceutical Innovation and Investment Conference highlighted the significant role of capital markets in supporting the globalization of Chinese innovative pharmaceutical companies, with Hong Kong Stock Exchange (HKEX) emerging as a leading platform for biotech financing in 2023 [1] Group 1: Market Performance - HKEX has positioned itself as a vital international financing platform for Chinese biotech companies, with the healthcare sector's IPO financing in Hong Kong ranking first globally this year [1] - As of now, Hong Kong has completed 12 biotech IPOs, raising a total of $1.3 billion, which is the highest globally [1] - The total amount raised through refinancing in the biotech sector has reached $4.1 billion this year, indicating a recovery in market confidence [1] Group 2: Regulatory Environment - The recent strong performance of Hong Kong's healthcare financing market is attributed to three interlinked factors: continuous optimization of regulatory systems, the listing of high-quality innovative companies, and active participation from investors [1] - The market is expected to see a significant rebound by 2025, reaffirming Hong Kong as the preferred listing destination for biotech companies [1]

Investment Rating - The report maintains a "Buy" rating for the company with a target price of 542 HKD [7]. Core Insights - The company is expected to report total revenue of 7.583 billion HKD for 3Q25, representing a year-on-year increase of 41% and a quarter-on-quarter increase of 5%. The net profit attributable to shareholders is projected to be 4.774 billion HKD, reflecting a year-on-year increase of 52% and a quarter-on-quarter increase of 7% [1][5]. - The significant increase in trading activity is the main driver of revenue growth, with the average daily turnover (ADT) for Hong Kong stocks reaching 286.4 billion HKD, a year-on-year increase of 141% and a quarter-on-quarter increase of 20% [1][2]. - The report anticipates a decrease in net investment income to 917 million HKD, a decline of 41% quarter-on-quarter, primarily due to a narrowing margin from margin investments as HIBOR decreases [4]. Summary by Sections Trading Activity - Trading-related revenue is expected to rise to 5.14 billion HKD, a quarter-on-quarter increase of 31%. The trading activity in Hong Kong stocks has reached new highs, with ADT increasing significantly [2]. - Southbound trading volume has also seen rapid growth, with a single-sided ADT of 76.2 billion HKD, a quarter-on-quarter increase of 36% [2]. IPO Market - The report estimates that IPO-related revenue for 3Q25 will be 440 million HKD, a quarter-on-quarter increase of 7.5%. The number of IPOs in 3Q25 is expected to be 25, with total fundraising amounting to 73.5 billion HKD [3]. Investment Income - The expected net investment income for 3Q25 is projected to be 917 million HKD, reflecting a significant decrease due to various factors including HIBOR fluctuations [4]. Profit Forecast and Valuation - The report adjusts the net profit forecasts for 2025, 2026, and 2027 to 17.7 billion HKD, 18.3 billion HKD, and 18.7 billion HKD respectively, with increases of 5.2%, 11.2%, and 14.1% [5].

Group 1 - The Hong Kong Stock Exchange (HKEX) has seen positive market reactions since launching its technology listing service in May, allowing for greater flexibility for companies to submit applications confidentially. Approximately 300 companies have applied for listings, with nearly half from the technology sector, followed by healthcare and biotechnology [1] - The HKEX aims to continue optimizing its listing processes to enhance flexibility for companies, and it is considering potential improvements to the dual-class share structure introduced seven years ago [1] - The HKEX's office in Riyadh, Saudi Arabia, has commenced operations, which is expected to strengthen communication and collaboration with regional partners. The first consumer company headquartered in the Middle East plans to list in Hong Kong, indicating initial success for the exchange [1] Group 2 - The HKEX emphasizes that it operates as a rules-based exchange, with the fundamental principle that listed companies must have substantial business operations. The exchange is currently researching virtual currency, focusing on how to optimize or advance market infrastructure related to virtual assets [2]

Core Insights - Investors today have a wide range of options for investment, including private markets and cryptocurrencies, making traditional stocks seem outdated [1][2] - Exchanges are increasingly collaborating rather than competing, reflecting a shift in the investment landscape [2] Market Performance - Stock markets are performing well, with indices reaching all-time highs, driven by retail investors engaging with popular companies and investment trends [3] - The U.S. market is showing signs of recovery, with more companies looking to go public, including private equity and government-backed firms [4] IPO Trends - Saudi Arabia has seen a significant increase in IPOs, rising from 8-9 annually to around 40-45 [5] - Hong Kong has completed nearly 80 IPOs recently, indicating a recovery in investor confidence regarding Chinese stocks [5] Investor Behavior - The rise in global IPOs is attributed to investors seeking diversification to mitigate market volatility caused by geopolitical uncertainties and protectionist policies [6] - There is a strong demand for investments in sectors like AI, semiconductors, and green technology, alongside a new trend in consumer products, exemplified by the popularity of Labubu dolls [6]

Announcement Details - The fund will resume subscription, redemption, and regular investment services starting from October 30, 2025, without further notice [1][2] - Investors are advised to make necessary arrangements in advance to avoid inconvenience due to the Hong Kong Stock Exchange's closure [1][2] Fund Operations - The fund's open days are aligned with Hong Kong Stock Connect trading days, and subscription and redemption can only be processed on these days [1] - The fund will suspend subscription, redemption, and regular investment services on October 29, 2025, as it is a non-Hong Kong Stock Connect trading day [1] New Distribution Channel - Starting from October 27, 2025, Zheshang Bank will be added as a distribution agency for the Huabao Cash Treasure Money Market Fund [3] - Only institutional investors can use this distribution channel for account opening, subscription, redemption, and other services [3]